Efficacy of coenzyme Q10 in prophylaxis of migraine headache

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20171112037413N1

Enrollment

112

Registered

2018-01-07

Start date

2017-12-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine. Migraine

Interventions

Intervention 1: Intervention group: Co Q10-100mg. Intervention 2: Control group: Propranolol (10 mg).

Treatment - Drugs

Intervention group: Co Q10-100mg

Control group: Propranolol (10 mg)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: migraine headache

Exclusion criteria

Exclusion criteria: Pregnancy serious disorders that have interaction with treatment of migraine

Design outcomes

Primary

Measure	Time frame
Severity, frequency, and duration of headache; nausea and vomiting; photophobia; Phonophobia. Timepoint: at the beginning of investigation and after 3 month. Method of measurement: questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElahe Hosseinpour

Kermanshah University of Medical Sciences

elahe.hosseinpour@kums.ac.ir+98 83 3429 0775

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026